M&A Deal Summary

Dermapharm Holding Acquires Arkopharma Laboratories

On July 30, 2022, Dermapharm Holding acquired life science company Arkopharma Laboratories from Montagu

Acquisition Highlights
  • This is Dermapharm Holding’s 3rd transaction in the Life Science sector.
  • This is Dermapharm Holding’s 1st transaction in France.

M&A Deal Summary

Date 2022-07-30
Target Arkopharma Laboratories
Sector Life Science
Buyer(s) Dermapharm Holding
Sellers(s) Montagu
Deal Type Add-on Acquisition

Target

Arkopharma Laboratories

Carros, France
Arkopharma Laboratories is a pharmaceutical laboratory specialised in the area of phytotherapy, natural medicine and dietary supplements. By offering a global approach to health and well-being, Arkopharma Pharmaceutical Laboratories meets consumers' needs. It offers natural medicines intended for treatment and prevention, increases consumption oriented towards family self-medication, and also offers healthcare professionals new possibilities for prescriptions. Arkopharma Laboratories was founded in 1980 and is based in Carros, France.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Dermapharm Holding

Grunwald, Germany

Category Company
Founded 1991
Sector Life Science
Employees3,497
Revenue 1.2B EUR (2024)
DESCRIPTION

Dermapharm Holding is a manufacturer of patent-free branded pharmaceuticals for selected markets. Its integrated business model includes in-house development, in-house production, and distribution of pharmaceuticals and other healthcare products to selected markets through a pharmaceutically trained sales force. Dermapharm Holding was founded in 1991 and is based in Grunwald, Germany.


DEAL STATS #
Overall 3 of 3
Sector: Life Science M&A 3 of 3
Type: Add-on Acquisition M&A Deals 2 of 2
Country: France M&A 1 of 1
Year: 2022 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-12-15 C3 Cannabinoid Compound

Neumarkt, Germany

C3 Cannabinoid Compound develops and manufactures pharmaceutical products and is comprised of Spectrum Therapeutics GmbH, based in Neumarkt-in-der-Oberpfalz, Germany, THC Pharm GmbH The Health Concept, based in Frankfurt, Germany, and Spectrum Therapeutics Austria GmbH, based in Vienna, Austria.

Buy €123M

Seller(S) 1

SELLER

Montagu

London, United Kingdom

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1968
PE ASSETS 11.0B EUR
Size Mega
Type Sector Agnostic
DESCRIPTION

Montagu is an independent private equity firm focused on European management buyouts and growth capital transactions. The Firm seeks opportunities valued between €100 million and €1 billion. Sectors of interest include healthcare, medical products, financial services, software, IT, information services, and education. Montagu dates back to 1968 and is based in London.


DEAL STATS #
Overall 73 of 76
Sector: Life Science M&A 4 of 4
Type: Add-on Acquisition M&A Deals 29 of 31
Country: France M&A 10 of 12
Year: 2022 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-07-19 EPFR

Boston, Massachusetts, United States

EPFR’s Flows and Allocations data provides a unique view of the investor and fund manager sentiment across global markets, helping buy and sell-side institutions make informed decisions. EPFR was formed in 1995 and is based in Boston, Massachusetts.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-08-04 Lloyd s List Intelligence

London, United Kingdom

Lloyd's List Intelligence is a provider of maritime data and intelligence, widely used across the shipping ecosystem, extending to the finance, legal, academic, insurance, and government sectors. Lloyd's List Intelligence was founded in 1972 and is based in London, United Kingdom.

Buy -